The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes
Diabetes Care - United States
doi 10.2337/diacare.28.9.2261
Full Text
Open PDFAbstract
Available in full text
Date
August 25, 2005
Authors
Publisher
American Diabetes Association